• Our Solution
    • Physicians
    • Patients
  • About Artrya
    • Who we are
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • ASX Announcements
    • Corporate Governance
    • Company Research
  • Contact Us
Request a demonstration

Notice of Annual General Meeting

Letter to Shareholders – Annual General Meeting

Proxy Form – Annual General Meeting

Artrya Annual Report 2022

Appointment of Company Secretary

Notification regarding unquoted securities – AYA

Application for quotation of securities – AYA

Appendix 4E and Annual Financial Report 30 June 2022

Appendix 4G and Corporate Governance Statement

Artrya Strengthens Board with US-based Director

Previous 1 … 11 12 13 14 15 16 17 … 20 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today
Coronary artery disease.
We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location
1257 Hay Street, West Perth, 6005
Follow us
X
LinkedIn

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719. Salix Central USA product (K243038) is cleared in the USA. For the availability of Salix in The EU, UK, or other jurisdictions, please contact us.

© 2025, Artrya. All rights reserved. Privacy Policy Terms and Conditions Indications for Use